Get the Stockscreener App
3.50
0.00%
0.00
After Hours:
3.50
Omniab Inc stock is traded at $3.50, with a volume of 803.54K.
It is up +0.00% in the last 24 hours and down -10.26% over the past month.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
See More
Previous Close:
$3.50
Open:
$3.5
24h Volume:
803.54K
Relative Volume:
1.96
Market Cap:
$423.54M
Revenue:
$34.16M
Net Income/Loss:
$-50.62M
P/E Ratio:
-21.94
EPS:
-0.1595
Net Cash Flow:
$703.00K
1W Performance:
-7.65%
1M Performance:
-10.26%
6M Performance:
-13.79%
1Y Performance:
-38.16%
1-Day Range:
$3.50
$3.685
1-Week Range:
$3.43
$3.95
52-Week Range:
$3.43
$6.715
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
3.50 | 423.54M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $542,000 Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Fmr LLC Acquires 13,324 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
OABI stock touches 52-week low at $3.55 amid market challenges - Investing.com
OmniAb (NASDAQ:OABI) Hits New 1-Year LowShould You Sell? - MarketBeat
OmniAb Unveils Revolutionary AI-Powered Antibody Discovery Platform, Launches Advanced OmniHub™ Portal - StockTitan
OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth By Investing.com - Investing.com South Africa
OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth - Investing.com India
Charles Schwab Investment Management Inc. Increases Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb (NASDAQ:OABI) Shares Down 5.5%Here's Why - MarketBeat
OmniAb CFO Kurt Gustafson sells $98,587 in stock By Investing.com - Investing.com Nigeria
OmniAb chief legal officer sells $33,130 in shares By Investing.com - Investing.com Nigeria
omniAb CEO Matthew Foehr sells $56,308 in stock By Investing.com - Investing.com Canada
omniAb CEO Matthew Foehr sells $56,308 in stock - Investing.com India
OmniAb chief legal officer sells $33,130 in shares - Investing.com India
OmniAb CFO Kurt Gustafson sells $98,587 in stock - Investing.com
First Sabrepoint Capital Management LP Sells 210,000 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
THARTharimmune, Inc. Latest Stock News & Market Updates - StockTitan
1,000,000 Shares in OmniAb, Inc. (NASDAQ:OABI) Acquired by Murchinson Ltd. - MarketBeat
OmniAb's SWOT analysis: antibody discovery firm's stock faces growth hurdles - Investing.com
35,081 Shares in OmniAb, Inc. (NASDAQ:OABI) Bought by Atria Investments Inc - Defense World
GSA Capital Partners LLP Decreases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
Janus Henderson Group PLC's Strategic Acquisition in OmniAb Inc - GuruFocus.com
OmniAb, Inc. (OABI) Reports Q3 Loss, Lags Revenue Estimates - MSN
Benchmark Reiterates "Buy" Rating for OmniAb (NASDAQ:OABI) - MarketBeat
OmniAb Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
OmniAb's (OABI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Earnings call: OmniAb reports Q3 financials and optimistic business outlook - Investing.com
OmniAb, Inc. (NASDAQ:OABI) Q3 2024 Earnings Call Transcript - Insider Monkey
OmniAb Inc (OABI) Q3 2024 Earnings Call Highlights: Strong Program Growth Amid Revenue Challenges - Investing.com Canada
OmniAb Reports Third Quarter 2024 Financial Results - TipRanks
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - StockTitan
OmniAb Inc (OABI) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
OmniAb (OABI) Scheduled to Post Earnings on Tuesday - Defense World
Villere ST Denis J & Co. LLC Cuts Holdings in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
Rice Hall James & Associates LLC Raises Stake in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
OmniAb to Participate in Two Investor Conferences in November - StockTitan
Bleakley Financial Group LLC Trims Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb to Report Third Quarter 2024 Financial Results on November 12 - StockTitan
The Manufacturers Life Insurance Company Invests $147,000 in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth? - Yahoo Finance
Millennium Management LLC Reduces Stock Position in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
Sei Investments Co. Has $109,000 Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Dimensional Fund Advisors LP Buys 194,835 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
American Century Companies Inc. Raises Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb's SWOT analysis: antibody discovery firm's stock faces pivotal 2H24 - Investing.com
OmniAb's SWOT analysis: antibody discovery firm's stock faces pivotal 2H24 By Investing.com - Investing.com UK
The Attractiveness of Investing In OmniAb Inc (OABI) is Growing - Knox Daily
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omniab Inc Stock (OABI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FOEHR MATTHEW W | President and CEO |
Dec 09 '24 |
Sale |
4.13 |
13,634 |
56,308 |
3,714,447 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Dec 09 '24 |
Sale |
4.13 |
23,871 |
98,587 |
200,661 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):